Case No. O2016_017 | Decision of 21 June 2019
The patent at stake is, again, MundiPharma‘s EP 2 425 825 B9; see EPO Register and Swissreg.
Déjà vu? Indeed! Mundipharma’s EP’825 declared invalid for the second time
→ Read more ...
Sign-up now for the next epi Roundtable on August 28, 2019
All European patent attorneys are members of the Institute of Professional Representatives before the European Patent Office (epi). epi represents the interests of its members in relation to the EPO.
Tackling questions of law and questions of fact, again …
The annual INGRES event of 2 July 2019 (‘Praxis des Immaterialgüterrechts’) has been very interesting and enjoyable, as always. I am not intending to anticipate the full report about the event that will be prepared by Estelle SEILER for publication in sic!, but there was one specific discussion following-up on Susanna RUDER‘s presentation that I am still digesting.
Alstom and Bombardier litigating over the Twindexx train; hearing canceled
Case No. O2017_015 | Hearing of 1 July 2019 (canceled)
First things first: The hearing scheduled for today did not take place.
No recusal of the judge-rapporteur — but there still is an elephant in the room …
Case No. 4A_56/2019 (Supreme Court) | Decision of 27 May 2019 on appeal against O2017_024 (FPC) | Order of 11 December 2018
The Supreme Court had to deal with an appeal against an (unpublished) order issued by the Administrative Commission (AC) of the FPC in case no.
The heat is on between Laurastar and Innosteam
Case No. O2018_016 | Hearing of 25 June 2019
Laurastar and Innosteam are litigating about ownership of two PCT applications, WO 2018/006994 A1 and WO 2018/036653 A1; see the EPO Register here and here.
A Swiss approach to the EPO’s gold standard
Case No. O2016_016 | Decision of 6 June 2019
The patent at stake is MundiPharma‘s EP 2 425 825 B9; see EPO Register and Swissreg.
Lilly’s patent on combination of pemetrexed and vitamin B12 challenged
Case No. O2018_003 ¦ Hearing of 17 June 2019
The patent in suit is Lilly‘s EP 1 313 508 B1; see the EPO Register and Swissreg for further information.
What’s the point about pointer?
Case No. O2016_017 | Hearing of 3 June 2019
The patent at stake is MundiPharma‘s EP 2 425 825 B9; see EPO Register and Swissreg.
Fumarate and phosphate: Same same, but different?
Case No. O2017_023 | Decision of 3 May 2019
This case is about an alleged infringement of Gilead’s SPC C00915894; the basic patent is (see EPO Register and Swissreg).
The money behind the pharmaceuticals being litigated
The Njardarson Group of the University of Arizona has just published the 2018 edition of the poster ‘Top 200 Pharmaceutical Products by Retail Sales‘ (file size is about 8 Mb).
Hip Hip Hooray: Stemcup and Implantec litigating about the ANA.NOVA hybrid socket
Case No. O2016_012 | Hearing of 29 May 2019
The patent in suit is EP 1 411 869 B1; see Swissreg and EPO Register for further information.